help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

A more recent version of this article appeared on July 1, 2007

Published online before print May 3, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.061099v1
171/1/87    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wesche-Soldato, D. E.
Right arrow Articles by Ayala, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wesche-Soldato, D. E.
Right arrow Articles by Ayala, A.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.061099


Accepted for publication March 27, 2007.


Article

CD8+ T Cells Promote Inflammation and Apoptosis in the Liver after Sepsis. Role of Fas-FasL

Doreen E. Wesche-Soldato*, Chun-Shiang Chung*, Stephen H. Gregory{dagger}, Thais P. Salazar-Mather{ddagger}, Carol A. Ayala*, and Alfred Ayala*@

From Surgical Research,* the Department of Surgery, Brown University School of Medicine and Rhode Island Hospital, Providence; and the Departments of Medicine{dagger} and Molecular Microbiology and Immunology,{ddagger} Brown University School of Medicine, Providence, Rhode Island

@ To whom correspondence should be addressed. E-mail: aayala{at}lifespan.org.


   Abstract

Although studies blocking the Fas pathway indicate it can decrease organ damage while improving septic (cecal ligation and puncture, CLP) mouse survival, little is known about how Fas-Fas ligand (FasL) interactions mediate this protection at the tissue level. Here, we report that although Fas expression on splenocytes and hepatocytes is up-regulated by CLP and is inhibited by in vivo short interfering RNA, FasL as well as the frequency of CD8+ T cells are differentially altered by sepsis in the spleen (no change in FasL, decreased percentage of CD8+ and CD4+ T cells) versus the liver (increased FasL expression on CD8+ T cells and increase in percentage/number). Adoptive transfer of CLP FasL+/+ versus FasL-/- mouse liver CD8+ T cells to severe combined immunodeficient or RAG1-/- recipient mice indicated that these cells could induce inflammation. The FasL-mediated cytotoxic capacity of these septic mouse liver CD8+ T cells was shown by their ability to damage directly cultured hepatocytes. Finally, although CD8-/- mice exhibited a reduction in both CLP-induced liver active caspase-3 staining and blood interleukin-6 levels, only FasL-/- (but not CD8-/-) protected the septic mouse spleen from increasing apoptosis. Thus, although truncating Fas-FasL signaling ameliorates many untoward effects of sepsis, the pathological mode of action is distinct at the tissue level.





This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Londono, A. Marques, R. L. Hornung, and D. Cadavid
IL-10 Helps Control Pathogen Load during High-Level Bacteremia
J. Immunol., August 1, 2008; 181(3): 2076 - 2083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.